429
Views
21
CrossRef citations to date
0
Altmetric
Short Communication

Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA

, , &
Pages 193-195 | Received 16 Sep 2016, Accepted 27 Dec 2016, Published online: 13 Jan 2017

References

  • Kemp AM, Clark MS, Dobbs T, et al. Top 10 facts you need to know about synthetic cannabinoids: not so nice spice. Am J Med. 2016;129:240–244.
  • Valiveti S, Hammel DC, Earles DC, et al. Transdermal delivery of the synthetic cannabinoid WIN 55,212-2: in vitro/in vivo correlation. Pharm Res. 2004;21:1137–1145.
  • Valiveti S, Kiptoo PK, Hammell DC, et al. Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro. Int J Pharm. 2004;278:173–180.
  • Paudel KS, Hammel DC, Agu RU, et al. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers. Drug Dev Ind Pharm. 2010;36:1088–1097.
  • Spaderna M, Addy HP, D’Souza DC. Spicing things up: synthetic cannabinoids. Psychopharmacology (Berl). 2013;228:525–540.
  • Tait RJ, Caldicott D, Mountain D, et al. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol. 2016;54:1–13.
  • Mckeever GR, Vearrier D, Greenberg MI. K2 – not the spice of life: synthetic cannabinoids and ST elevation myocardial infarction: a case report. Clin Toxicol. 2014;52:362–363.
  • Streich HT, Rushton WF, Charlton NP. Death by spice: a case report of mortality following synthetic cannabinoid use. Clin Toxicol. 2014;52:365.
  • Manini AF, Hoffman RS, Stimmel B, et al. Clinical toxicity of synthetic cannabinoid receptor agonist use. Clin Toxicol. 2015;53:356–357.
  • Angerer V, Moosmann B, Franz F, et al. 5F-cumyl-PINACA in “e-liquids” for electronic cigarettes – a new type of synthetic cannabinoid in a trendy product. 7th European Academy of Forensic Science Conference; 2015 Sep 10; Prague, Czech Republic.
  • Hua T, Vemuri K, Pu M, et al. Crystal structure of the human cannabinoid receptor CB1. Cell. 2016;167:750–762.
  • Banister SD, Moir M, Stuart J, et al. Pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. ACS Chem Neurosci. 2015;6:1546–1559.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.